Professor Udai Banerji's group conducts early investigations of new anticancer agents developed in the Centre for Cancer Drug Discovery.
Professor Udai Banerji champions multidisciplinary working at the interface between early phase clinical trials, drug discovery and translational research related to drug resistance. He is Deputy Director of the Drug Development Unit at The ICR and Royal Marsden, and as a key member of the Centre for Cancer Drug Discovery, also heads the Clinical Pharmacodynamics Biomarker Group and the Clinical Pharmacology-Adaptive Therapy Group.